You are here

Article info

Article menu
Download PDFPDF
Editorial commentary
MR spectroscopy, a new in vivo biomarker for dementia disorders?

Authors

  1. Correspondence to Professor Lars-Olof Wahlund, Section for Clinical Geriatrics, Department of NVS, Karolinska Institutet, Hälsovägen 7, Novum floor 5, Stockholm S-14186, Sweden; lars-olof.wahlund{at}ki.se
View Full Text

Citation

Wahlund L
MR spectroscopy, a new in vivo biomarker for dementia disorders?
Journal of Neurology, Neurosurgery & Psychiatry 2015;86:1284-1285.

Publication history

  • Received July 26, 2015
  • Revised August 18, 2015
  • Accepted August 28, 2015
  • First published September 10, 2015.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/